🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

CODX CODX

Company Profile ↓
$1.51
-80.42% 1Y
P/E-0.04
52W High$37.80
52W Low$1.28
EPS (TTM)$-35.25

Company Overview

CODX (CODX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 73.3% CAGR over the past five years.

Recent Developments

  • Dec 2025 Revenue of $622.49K (-84.1% YoY); net profit $-46.90M.
  • Trailing 12 Months Year-on-year growth — revenue -84.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR 73.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:73.27%
1 Year:-84.10%

Stock Price Performance

1 Year:-80.42%
6 Months:-35.74%
3 Months:-5.03%
1 Month:-44.28%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 1% of range
$1.28 $37.80
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)30.27 · Neutral
Price Performance
1M-44.28%
3M-5.03%
6M-35.74%
1Y-80.42%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 73.3% over 5 years.

CONS

  • Trading 96.0% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.04
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
73.27%
Profit 5Y
-
Revenue (YoY)
-84.10%
Earnings (YoY)
-

Profitability & Returns

ROCE
-147.54%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
Gross Margin
64.28%
EPS (Latest Qtr)
$-4.06
EPS (TTM)
$-35.25

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$21.50M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$622.49K
EBITDA
$-30.18M
Free Cash Flow
$-29.84M
Operating Cash Flow
$-29.14M
Shares Outstanding
-
Gross Margin
64.28%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ---2.47K2.60K9.70K9.70K9.70K3.40K61.57K41.43K1.55M24.04M21.82M20.02M27.36M30.10M22.70M5.02M5.09M601.96K197.81K2.46M467.85K2.66M641.14K50.28K162.91K145.38K145.95K
Gross Profit ---2.16K2.60K9.70K9.70K9.70K2.95K22.77K21.07K1.07M18.06M16.00M16.75M24.85M26.79M19.42M4.11M4.33M99.72K-261.29K2.20M233.35K2.44M343.74K28.69K130.80K119.09K-47.81K
Operating Income -390.29K-392.35K-564.37K-700.95K-1.81M-1.28M-1.35M-1.66M-1.25M-1.37M-1.65M-1.08M14.71M12.04M10.33M11.79M13.63M9.82M-4.15M-6.54M-9.95M-11.99M-8.94M-10.26M-7.68M-10.23M-8.55M-8.06M-7.01M-9.21M
Net Income -442.64K-449.95K-705.74K-855.01K-3.89M-1.31M-1.37M-1.64M-1.37M-1.34M-1.75M-1.07M15.01M15.73M7.90M9.79M11.48M11.71M-2.69M-1.36M-5.76M-8.92M-5.98M-9.31M-7.60M-9.70M-7.53M-7.73M-5.89M-9.14M
Diluted EPS 1,143,939.004,141,667.00-3,529,896.001,028,969.00-----0.08-0.10-0.050.510.530.260.330.380.34-0.08-0.04-0.20-0.31-0.20-0.31-0.25-0.32-7.05-0.23-0.16-4.06
R&D Expense 172.11K172.80K265.69K184.88K272.21K297.42K357.89K330.42K347.31K312.59K331.03K400.02K750.25K921.89K2.22M4.67M5.89M3.77M3.89M5.04M5.01M5.98M5.79M5.68M5.61M4.88M4.87M4.69M4.48M5.93M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -7.66K39.91K214.97K74.55M97.89M34.22M6.81M3.92M622.49K
Cost of Revenue ------5.48M4.18M999.12K222.38K
Gross Profit -7.36K30.52K102.54K57.96M86.31M28.74M2.63M2.92M400.11K
Operating Expenses ------40.33M45.33M43.00M31.68M
Operating Income -1.69M-4.56M-6.12M-5.89M41.69M46.06M-11.59M-42.71M-40.08M-31.28M
EBITDA -------10.31M-41.48M-38.70M-30.18M
Interest Expense ----------
Pretax Income -------18.85M-38.11M-37.58M-48.51M
Tax Provision -------4.61M-2.78M57.37K-1.62M
Net Income -1.93M-6.96M-6.27M-6.20M42.48M36.66M-14.24M-35.33M-37.64M-46.90M
Diluted EPS ----0.371.521.23-13.50-36.00-37.22-35.25
R&D Expense 731.47K1.00M1.36M1.37M3.19M14.96M17.44M22.96M20.98M19.14M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -1.30M4.66M1.55M2.22M71.24M160.03M123.09M95.32M63.56M24.74M
Total Equity -1.15M-2.99M3.85M-1.06M1.74M66.70M134.48M114.52M85.58M53.88M20.63M
Cash & Equivalents 33.80K998.74K3.53M950.24K893.14K42.98M88.61M22.97M14.92M2.94M11.88M
Long Term Debt ---1.91M-------
Total Liabilities -4.29M811.80K2.61M478.07K4.54M25.56M8.57M9.31M9.69M4.11M
Current Liabilities -3.85M628.26K2.35M328.07K4.06M12.60M3.87M5.75M7.32M3.54M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -1.31M-3.21M-4.08M-5.53M28.17M41.08M6.57M-22.08M-29.16M-29.14M
Investing Cash Flow -12.24K-189.31K-380.34K-435.25K-5.82M4.10M-58.17M15.39M17.07M26.27M
Financing Cash Flow 2.29M5.94M1.88M5.90M19.74M450.40K-14.03M-1.36M103.91K11.81M
Capital Expenditure -12.24K-129.31K-41.34K-113.25K-774.40K-669.46K-1.43M-1.37M-748.35K-700.05K
Free Cash Flow -1.32M-3.34M-4.12M-5.64M27.39M40.41M5.14M-23.45M-29.90M-29.84M
Share Buybacks ------14.21M1.36M--

Ratios (Annual)

Figures in %.

Metric Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -96.1%76.5%47.7%77.7%88.2%84.0%38.6%74.5%64.3%
Operating Margin % --59,567.6%-15,328.6%-2,741.6%55.9%47.1%-33.9%-626.9%-1,023.7%-5,025.5%
Net Margin % --90,827.9%-15,714.3%-2,882.0%57.0%37.5%-41.6%-518.7%-961.4%-7,533.6%
ROE % 64.4%-180.7%592.3%-356.6%63.7%27.3%-12.4%-41.3%-69.9%-227.3%
ROCE % 66.2%-113.1%765.9%-312.3%62.1%31.2%-9.7%-47.7%-71.3%-147.5%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CODX

Google News Wed, 05 Aug 2026

CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Stocktwits

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNTGw2UkRJNlhjWkN2bFZVZkFFZHpYMWVibUJuN3F2Q3pvTGdTVGVUS2dkYzlnV1p1NUJXN0hkN0dBdjFYcU5hTWY2S2l4VnZrRFNkU2tKNHBTVUxNRWJ3VHVRZXl2SkZ2bzZFM3dpS211R0dvem5OYng3ZV9Ua2RSUld5V3JXSDd2VzYyM3…

Google News hu, 16 Jul 2026

Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer - PR Newswire

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOb3JZODlnLXhpVHNLUHdkTS02N1pHdWFJU2JRRDJpMGg3ZXpodUpvc3ItUmZkeDU5azFLaEZvOFI4OG9ibU53TW9JbEJMSTlqV0VLSmNIN3lxWUhRRXZ4WFMxbGxCRDVpYnhveUpuTlJlbGJ2ZG12bFR3NjNSMVFmdHpUaFFYYWFqeWZRWF…

Google News hu, 30 Jul 2026

Co-Diagnostics Plans Aug. 13 Webcast on Second-Quarter Results - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxObl96Y3ZfSUtUZEdtSTJCRm56RUNSWXpIZUVPVV9RV2tSdlViWWg2ZURISkcxSVNybmFhc1pZa2xCb2hWZ2NoSEpKT0tqckthT0o1Z0FZaXp0Vk9nbzNlVUp0S3ZaM2JZWGZ6ZnMxWllGVGVvNFRQSVQ2QzZYVHNaTVRZQ3ItWGtpOFZad2…

Google News Wed, 29 Jul 2026

Why Did CODX Stock Nearly Double In Value Today? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNMC14UUpQWkNGelFOUVo4LVBNWWQwbkxudG9VYXZxcTlIWVItX1F4UVFQS0tEYUxzZzZGblBTN2JnSnhVV0RrSjcyZ1BDcFF5X09DUS1hbTFwYVVFSnNLY1gtaTFuaEpGak9SNUdadDEtMUxqclp2WG4tZ2FLSHNfT05FTENaR1N5RFNSZz…

Google News Fri, 24 Jul 2026

Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo

<a href="https://news.google.com/rss/articles/CBMiiwNBVV95cUxPMHdsQXMzMV9yMjFtT3Y0SEZDRkcwQnZNYXVaMHpNS2dFSHJZandJYXROTGxUQnZpZnFNbU82YjNnM0xiWXNGeHI3ZVU1V3RFU1Bocm5DU1l1NzRFQ2FfVHA3NGVibG5aUEhJb0NzMnhMNTUwSWxjZzVVRjVRYTdneG5vS3BlaG9nbkhxcn…

Google News Sat, 01 Aug 2026

Co-Diagnostics, Inc. Revenue Breakdown – NASDAQ:CODX - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFB3Q2xxaURUUThfNW5PZGpqR2FsU2dzVVJrWlJhbm9jdkZfR1RZRGNHUEFYNG5UVzZnSHNMY2t0N3RXWkI3d2lNcTRhcXBLb0tqY3FsaTlmY3NEZVR3Vi11bG41aGpoS2NnNmpRSlB3X29ZTkVvR0tJ?oc=5" target="_blank">Co-Diag…

CODX — Frequently Asked Questions

What is the current share price of CODX?

As of 2026-08-05 17:25 PDT, CODX trades at $1.51 on NASDAQ/NYSE. Its 52-week range is $1.28 to $37.80.

What is the P/E ratio of CODX?

CODX trades at a trailing price-to-earnings (P/E) ratio of -0.04.

Is CODX a good stock to buy?

This page provides a data-driven analysis of CODX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space